Early over-expression of GRP receptors in prostatic carcinogenesis

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist

(2013) F. G. Rick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting

(2012) Meike Körner et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Pharmacokinetic Studies of 68Ga-Labeled Bombesin (68Ga-BZH3) and F-18 FDG PET in Patients With Recurrent Gliomas and Comparison to Grading

(2011) Antonia Dimitrakopoulou-Strauss et al.   CLINICAL NUCLEAR MEDICINE

Precursors of prostate cancer

(2011) David G Bostwick et al.   HISTOPATHOLOGY

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

(2011) Anna Imhof et al.   JOURNAL OF CLINICAL ONCOLOGY

Radiopeptide Imaging and Therapy in Europe

(2011) V. Ambrosini et al.   JOURNAL OF NUCLEAR MEDICINE

High expression of NPY receptors in the human testis

(2011) Meike Körner et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours

(2010) Rosalba Mansi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy

(2010) Kjell E. Öberg et al.   GASTROENTEROLOGY

Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides

(2009) R. Mansi et al.   CLINICAL CANCER RESEARCH

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with 111In-Pentetreotide

(2009) Dik J. Kwekkeboom et al.   NEUROENDOCRINOLOGY

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastrin-Releasing Peptide Receptor Imaging in Human Breast Carcinoma Versus Immunohistochemistry

(2008) C. Van de Wiele et al.   JOURNAL OF NUCLEAR MEDICINE

Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting

(2008) R. Cescato et al.   JOURNAL OF NUCLEAR MEDICINE

International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States

(2008) R. T. Jensen et al.   PHARMACOLOGICAL REVIEWS

Precursor lesions to prostatic adenocarcinoma

(2008) Jonathan I. Epstein   VIRCHOWS ARCHIV